RxDoctor Payments Data

Ashley Saunders

Family · Provo, UTNPI 1003680117

Payments from drug & device makers

$1,212in general payments, 2019–2025

Across 66 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$387
  • Lilly USA, LLC$256
  • GSK$151
  • Boehringer Ingelheim$79
  • AstraZeneca$51
  • Corcept Therapeutics$45
  • plus $243 from 12 others

What the payments were for

  • Food & beverage$1,212100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,212 in reported general payments places this provider in the 75th percentile of 1,460 family providers in Utah.

See all family providers in Utah

Medicare billing

Part B allowed, 2024
$31,739
Medicare patients
198
Services billed
745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide19$19,035
JardianceEmpagliflozin12$12,776
Omeprazole31$643
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide11$375
Bupropion XlBupropion Hcl19$369
Lisinopril19$319
Sertraline Hcl13$318
Atorvastatin Calcium25$313
Metformin Hcl ErMetformin Hcl14$305
Rosuvastatin Calcium14$289
Hydroxyzine Hcl12$288
Spironolactone11$279
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$236
Celecoxib13$216
Metformin Hcl11$188

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$256$19,03519 claims
Boehringer IngelheimJardiance$79$12,77612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,460 family providers in Utah.

Other family in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →